Michael T. Cullen - Oct 4, 2022 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role: Director, 10%+ Owner
Signature: /s/ Joshua L. Colburn, Attorney-in-Fact
Stock symbol: PBLA
Transactions as of: Oct 4, 2022
Transactions value $: $0
Form type: 4
Date filed: 10/6/2022, 06:14 PM
Previous filing: May 27, 2021
Next filing: Mar 29, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBLA	Common Stock	Purchase		+165K	+80.65%		370K	Oct 4, 2022	By Cullen Living Trust Dated April 23, 2009	F1
holding	PBLA	Common Stock						217K	Oct 4, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBLA	Warrants (right to buy)	Purchase	$0	+247K		$0.00	247K	Oct 4, 2022	Common Stock	247K	$0.30	By Cullen Living Trust Dated April 23, 2009

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $0.30 per share and warrant.